Log In
Print
BCIQ
Print
Print this Print this
 

CTx-0357927

  Manage Alerts
Collapse Summary General Information
Company Cancer Therapeutics CRC Pty. Ltd.
DescriptionInhibitor of VEGF receptor 3 (FLT4; VEGFR-3)
Molecular Target Vascular endothelial growth factor (VEGF) receptor 3 (FLT4) (VEGFR-3)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationMelanoma
Indication DetailsTreat melanoma
Regulatory Designation
Partner Bionomics Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today